Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hemorrhage | Phase 2 | ClinicalTrials |
| Heart Diseases | Phase 4 | ClinicalTrials |
| Afibrinogenemia | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemostatic Disorders | Phase 2 | ClinicalTrials |
CONTENTS
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hemorrhage | Phase 2 | ClinicalTrials |
| Heart Diseases | Phase 4 | ClinicalTrials |
| Afibrinogenemia | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemostatic Disorders | Phase 2 | ClinicalTrials |